Endometriózis: ki dolgozik rajta

Intézményenként egy kártya. Válassz célpontot, és csak az azon dolgozó csoportok maradnak.

• Minden célpont
• VEGF 0
• CTNNB1 0
• PPAR 0
• PI3K 0
• TP53 0
• AKT 0
• NLRP3 0
• TNF 0
• IL-6 0
• MMP-9 0
• NRF2 0
• AMPK 0
• ERK 0
• HIF-1 0
• JAK 0
• mTOR 0
• PTEN 0
• SIRT1 0
• TLR4 0
• HSP90 0
• MAPK 0
• STAT3 0
• BRCA1 0
• COX-2 0
• CXCR4 0
• EGFR 0
• ESR1 0
• HMGB1 0
• IL-1 0
• PD-1 0
• PKM2 0
• STING 0
• YAP 0
• BAP1 0
• BCL-2 0
• BDNF 0
• BRCA2 0
• CCR5 0
• CGRP 1
• CSF1R 0
• FAK 0
• FGFR 0
• FOXP3 0
• G6PD 0
• GPX4 0
• JNK 0
• KRAS 1
• LAG-3 0
• MDM2 0
• MYC 0
• PARP 0
• PD-L1 0
• PDGFR 0
• PRMT5 0
• SGLT2 0
• TIGIT 0
• TREM2 0
• VHL 0

Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-GF

  Tracking the Intestinal Permeation and Circulation Effects of Environmental MicroPlastics (TRACE-MP)

  Queen Mary University of London· London, Egyesült Királyság· EU contribution 292 073 EUR· until 2029. jan.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  Uro-Lieve: Slow-Release Capsaicin Hydrogel for Disease-Modifying Therapy of Painful Bladder Syndrome

  University of Galway· Galway, Írország· EU contribution 150 000 EUR· until 2027. nov.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-ERC-POC

  Simultaneous Yield of Non-invasive uterine Contractions via Wearable Observation and Real-time Monitoring A wearable platform for dynamic uterine motion capture. (SyncWorm)

  Gottfried Wilhelm Leibniz Universitaet Hannover· Hannover, Németország· EU contribution 150 000 EUR· until 2027. nov.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-SE

  Untapping the potential for improved female reproductive healthcare: diagnosing and reinforcing the status of UTERINE-associated fertility (TULIP)

  Karolinska Institutet· Stockholm, Svédország· EU contribution 1 803 600 EUR· until 2029. dec.· 6 countries

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Investigating how somatic mutation induced changes in the eutopic endometrial microenvironment cause endometriosis (MERMAID)

  Stichting Radboud Universitair Medisch Centrum· Nijmegen, Hollandia· EU contribution 232 916 EUR· until 2027. dec.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Developing a web-based sexual health support program (AURORAS) for urogenital cancer survivors

  Universidade Do Porto· Porto, Portugália· EU contribution 207 183 EUR· until 2027. aug.

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF

  Repro-Fiction: Synthesising Literature and Reproductive Healthcare (REPROFIC)

  Vilniaus Universitetas· Vilnius, Litvánia· EU contribution 181 136 EUR· until 2027. aug.· 2 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-EIC-ACC

  TRANSFORMATIVE NON-INVASIVE CAUSAL MECHANOSTICS PLATFORM TO EFFECTIVELY TRIAGE AND TREAT ENDOMETRIOSIS (TRANSCEND)

  Precisionlife Ltd· Witney, Egyesült Királyság· EU contribution 2 494 291 EUR· until 2027. máj.· 3 countries

• European Commission (Horizon Europe) · HORIZON-EIC

  PELVIc Floor Evaluation live TRACKing – Real-time prediction of perineal trauma (PELVITRACK)

  Institut Mines-Telecom· Palaiseau, Franciaország· EU contribution 3 209 103 EUR· until 2029. márc.· 7 countries

  The disease is named only in the funder's project summary, not in the title.

• European Commission (Horizon Europe) · HORIZON-RIA

  EUmetriosis: Transforming endometriosis care in Europe: an integrated approach to enhance understanding, diagnosis, tailored management and patient empowerment

  Universite Catholique de Louvain· Louvain la Neuve, Belgium· EU contribution 6 981 844 EUR· until 2029. dec.· 7 countries

10 of 14 running projects, newest first. Listed amounts together: 27,6 M EUR.

Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.

Vizsgálatok, amelyek regiszteradata szerint az egyéni résztvevői adatokat (IPD) megosztják.

Ebben a nézetben egy vizsgálat sem jelzi, hogy megosztaná a résztvevői adatokat.

Publikációk erről a betegségről egy MeSH-módszerkifejezés szerint, például szekvenálási vagy képalkotó módszerre.

• Single-Cell Analysis 21
• Organoids 13
• Mendelian Randomization Analysis 29
• CRISPR-Cas Systems 1
• Gene Expression Profiling 44
• Sequence Analysis, RNA 6
• Exome Sequencing 2
• Proteomics 12
• Metabolomics 7
• Mass Spectrometry 2
• Flow Cytometry 7
• Immunohistochemistry 18
• Liquid Biopsy 1
• Xenograft Model Antitumor Assays 1
• Positron-Emission Tomography 3
• Magnetic Resonance Imaging 53
• Machine Learning 31
• Deep Learning 4
• Cohort Studies 48
• Genome-Wide Association Study 34

• Single-Cell RNA Sequencing Reveals Immune Dysregulation and Candidate Drug Targets in Endometriosis.

  Cells, 2026. szept.

• Single-Cell RNA Sequencing Shows Markedly Elevated Immune Cell Proportions in the Endometrium of Women with Endometriosis-A Narrative Review.

  Int J Mol Sci, 2026. aug.

• Single-nucleus analysis of menstrual fluid highlights gene expression differences in epithelial cells of endometriosis donors.

  BMC Med, 2026. jún.

• Unraveling the significance of decorin in endometriosis development through single cell sequencing and experimental approaches.

  PLoS One, 2026. máj.

• Cell Subtypes and Gene Dysfunction in Ovarian Endometriosis Before and After GnRHa Treatment Revealed by Single-Cell RNA Sequencing.

  Reprod Sci, 2026. febr.

• Global RNA expression analysis of patient samples identified potential diagnostic biomarkers specific for peritoneal, ovarian and deep endometriosis.

  Sci Rep, 2026. jan.

Megmutatjuk, a betegség mely célpontjait említi az absztrakt, és onnan a rajtuk dolgozókhoz jutsz.